Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
AVATAR: AVR Vs Watchful Waiting in Asymptomatic Severe AS
Author(s): Marko Banovic Added: 2 years ago
In this short video interview, Dr Marko Banovic (Clinical centre of Serbia, Belgrade, RS) discusses the AVATAR Trial. The trial evaluated aortic valve replacement (AVR) compared with conservative therapy among patients with asymptomatic severe aortic stenosis. Presented first at AHA 2021, the trial showed that early AVR was beneficial at preventing adverse events among patients with asymptomatic… View more

Vascular Disease and Surgery

Intervention
TCT 22: 1Y Outcomes of Portico™ Valve in Pts with Severe Aortic Stenosis
Added: 1 year ago
TCT 22 - Prof Helge Möllmann joins us to discuss the findings of a study that aimed to evaluate the procedural safety and device performance of Abbott's Portico™ TAVI Valve in patients with severe symptomatic degenerative aortic stenosis. Originally presented at TCT 22, The CONFIDENCE Registry involved over 1000 patients with NYHA Class ≥ II Aortic Stenosis who received transcatheter aortic… View more

Intervention
Transcatheter LAA Closure
Author(s): Chirag Bavishi Added: 11 months ago

Vascular Disease and Surgery

Electrophysiology & Arrhythmia
Intrepid TMVR: Results Show Improved NYHA Class at 30 Days
Author(s): Firas Zahr Added: 2 years ago
In this video interview, Dr Firas Zahr (OHSU Hospital, Portland, OR, US) outlines the 30-day outcomes of the Intrepid TMVR Early Feasibility Study, originally presented at TCT 2021. This was a prospective multicenter trial, designed to study the feasibility of the Intrepid TMVR System. At 30 days, findings show favourable haemodynamics and an improved NYHA class in patients with mitral… View more

Intervention
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 5 months ago
What are the top late-breaking trials from #TCT2023? TCT 2023 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference. Dive into this practical and engaging discussion and learn more about the… View more

Intervention
Kendra J Grubb
Job title: Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine. Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease. Her… View more
Job title: Cardiothoracic Surgeon
Mr Adrian Pick graduated in 1993, from the Melbourne University Medical School then completed overseas fellowships at the MAYO clinic and the Toronto General Hospital. His interests include minimal access surgery for thoracic and cardiac surgery with emphasis on mitral valve repair and limited access aortic valve replacement. He is also committed to maximizing surgical treatment for both… View more
Vinayak Bapat
Job title: Surgical Director, Mitral and Tricuspid Therapies
Surgical Director, Mitral and Tricuspid Therapies at NewYork-Presbyterian/ Columbia University Medical Center. Dr. Bapat is also an assistant professor of surgery at CUMC.Dr. Bapat specializes in the minimally invasive and percutaneous treatment of structural heart disease with a focus on mitral and tricuspid therapies.Dr. Bapat did a fellowship program at Royal College of Surgeons in Edinburgh… View more
Research Area(s) / Expertise: Job title: Interventional Cardiologist
Dr Anita Asgar is an Interventional Cardiologist working at the Montreal Heart Institute,and Associate Professor of Medicine at the University of Montreal. Dr Asgar specialises in transcatheter valve interventions, congenital interventions and cardiac MRI. She is the lead cardiologist for the transcatheter mitral/tricuspid valve program at the Montreal Heart Institute. Her research interests… View more
View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 11 months ago
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science. Studies include:… View more

Intervention